High materiality7/10
UBS Resumes Charles River Labs (CRL) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS initiates Buy on CRL; target $357; last price $295.96.
- CRL upgraded to Buy by UBS
- Target $357
- Posted price $295.96
Key facts
- 01
Target: $357
- 02
Posted price: $295.96
- 03
Analyst firm: UBS
- 04
Analyst: Kevin Caliendo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.